RBP1 AS A MOLECULAR BIOMARKER FOR PREDICTING SURVIVAL AND RESPONSE TO TREATMENT IN GLIOMA

摘要

Disclosed herein are methods for detecting the presence of an isocitrate dehydrogenase mutation in a sample from a subject. Also disclosed are methods diagnosing and treating subjects having a cancer including determining whether the cancer may likely be treated with one or more retinoids.